BeStock  
Stocks › Biotechnology › TYRA

TYRA BIOSCIENCES, INC. TYRA

US equityMarket cap rank #2928Biotechnology
$20.12 +$0.39 (+1.98%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $20.29 +0.84%
Open$19.62
Prev close$19.73
Day range$19.48 – $20.44
Volume467.6K
Market cap$1.39B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership114.7%-2.68 pts vs. prior quarter
Institutions holding202-5 vs. prior quarter
Insider trades (recent)31 buys / 18 sellsNet buying
Short interest14.40% of floatDays to cover 15.3 · as of 30 Oct 2026
Short-sale volume share26.8%5-day average of daily volume

Short-sale volume as % of daily volume

16%26%36%46%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$1.45M (1 inflow days, 19 outflow days).

Net flow by order size, last 20 sessions

−$943.8KSuper−$509.9KBig−$2.2MMid−$3.4MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 50.8% of shares outstanding.

Largest holders

  • RA Capital Management, L.P.17.66%
  • FMR15.25%
  • Janus Henderson Group plc6.30%
  • BVF Partners L.P.6.10%
  • Alta Partners LP5.53%
  • Nextech Invest Ltd.5.14%
  • Paradigm Biocapital Advisors LP5.03%
  • Artal Group S.A.4.92%

By investor type

  • Mutual Fund46.46%
  • VC/PE Fund40.83%
  • Hedge Fund24.13%
  • Individual/Insider2.27%
  • Public Company1.89%
  • Private Company0.62%
  • Sovereign Wealth Fund0.25%
  • Government Pension Fund0.20%

Reported short interest has fallen from 16.24% to 14.40% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Artal Group S.A. VC/PE Fund 2026/Q3 +2,670,887 4.9%
FMR Mutual Fund 2026/Q3 +1,617,950 15.3%
Franklin Resources Mutual Fund 2026/Q3 +648,194 1.2%
BlackRock Mutual Fund 2026/Q3 +272,686 4.8%
Vanguard Capital Management, LLC Mutual Fund 2026/Q3 +259,693 2.6%
BVF Partners L.P. Hedge Fund 2026/Q3 +2,739,690 6.1%
Paradigm Biocapital Advisors LP Hedge Fund 2026/Q3 +1,644,846 5.0%
T. Rowe Price Group, Inc. Mutual Fund 2026/Q3 +1,796,506 4.0%
FMR Mutual Fund 2026/Q3 +1,172,865 13.0%
Hood River Capital Management LLC Mutual Fund 2026/Q3 +1,016,775 1.5%
State Street Global Advisors Mutual Fund 2026/Q3 +924,290 3.1%
BlackRock Mutual Fund 2026/Q3 +814,043 4.4%
Artal Group S.A. VC/PE Fund 2026/Q3 +725,000 1.1%
Deerfield Management Company, L.P. Hedge Fund 2026/Q3 +468,000 1.5%
Janus Henderson Group plc Mutual Fund 2026/Q3 +461,859 6.3%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
14 Sep 2026 Alan Fuhrman Chief Financial Officer Other Acquisition +951 $9.13 17,115
14 Sep 2026 RA Capital Management, L.P. Open Market Derivative Acquisiti +9,078,529 $0.00 11,616,986
14 Sep 2026 Todd Harris Chief Executive Officer Other Acquisition +864 $9.13 1,359,495
14 Sep 2026 Julia Rueb VP of Finance & Principal Accounting Officer Other Acquisition +2,925 $9.13 11,258
8 Sep 2026 Rehan Verjee Independent Director Open Market Acquisition +971 $20.58 972
27 May 2026 Robert J. More Independent Director Other Derivative Acquisition +13,160 $32.68 13,160
27 May 2026 RA Capital Management, L.P. Other Derivative Acquisition +13,160 $32.68 13,160
27 May 2026 Adele M. Gulfo Independent Director Other Derivative Acquisition +13,160 $32.68 13,160
27 May 2026 Rehan Verjee Independent Director Other Derivative Acquisition +13,160 $32.68 13,160
27 May 2026 S. Rothenberg Independent Director Other Derivative Acquisition +13,160 $32.68 13,160
27 May 2026 Jake Simson Independent Director Other Derivative Acquisition +13,160 $32.68 13,160
27 May 2026 Susan Moran Independent Director Other Derivative Acquisition +13,160 $32.68 13,160
4 May 2026 Alan Fuhrman Chief Financial Officer Other Acquisition +20,000 – 20,000
4 May 2026 Alan Fuhrman Chief Financial Officer Other Derivative Acquisition +67,000 $33.93 67,000
4 May 2026 Todd Harris Chief Executive Officer Other Acquisition +79,000 – 79,000
4 May 2026 Todd Harris Chief Executive Officer Other Derivative Acquisition +265,000 $33.93 265,000
4 May 2026 Bhavesh Ashar Chief Operating Officer Other Acquisition +15,013 – 15,013
4 May 2026 Bhavesh Ashar Chief Operating Officer Other Derivative Acquisition +50,295 $33.93 50,295
4 May 2026 Douglas Warner Chief Medical Officer Other Acquisition +25,000 – 25,000
4 May 2026 Douglas Warner Chief Medical Officer Other Derivative Acquisition +85,000 $33.93 85,000

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 9,901,757 14.4% 15.3
15 Oct 2026 9,495,754 13.8% 15.3
30 Sep 2026 9,414,018 13.7% 8.8
15 Sep 2026 9,876,964 14.4% 5.7
31 Aug 2026 9,440,216 15.8% 27.1
14 Aug 2026 9,689,392 16.2% 12.7

Discussion

No comments yet — be the first to weigh in on TYRA.

Sign in to join the discussion.

Scroll to Top